AI
This comes after it launched its CDI tool called DxPrime in June.
According to the World Health Organization, breast cancer survival rates vary significantly between different countries.
One of the projects will develop a digital navigator to support people with chronic conditions.
It will be used to accelerate collaborations with pharmaceutical firms.
It will use its latest funds for its global expansion.
The company also has pending approvals for the device in Australia and Thailand.
Also, engineers from the University of Hong Kong have come up with a tiny biosensing platform for personalised health monitoring.
Also, a new online repository of health and wellness knowledge has been launched in India.
Also, annalise.ai has made key executive appointments to support its global expansion.
They have so far developed AI prediction models for breast, colon, and lung cancers.